Navigation Links
Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
Date:12/5/2007

tol-Myers Squibb Company, Genentech, Inc. and N.V. Organon. For additional information about Lexicon and its programs, please visit http://www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX6171 and the potential therapeutic and commercial potential of LX6171. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX6171 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
9. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
10. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would ... some recent company developments. As Medifirst continues to expand ... with shareholders. Integrating social media into its investor relations ... will post updates on Twitter.  The Facebook homepage is ... Says CEO Bruce J. Schoengood ...
(Date:5/22/2013)... , May 22, 2013 Ranbaxy ... Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), announced on ... in recent years to address past conduct under ... Daiichi Sankyo continues to support ... the conduct of the past which led to ...
(Date:5/22/2013)... REHOVOT, Israel , May 22, 2013 ... a leading developer and provider of microRNA-based molecular diagnostics, ... President and Chief Executive Officer of Rosetta Genomics, will ... Conference taking place from June 3-6, 2013 in New ... Tuesday, June 4 th at 2:00 p.m. Eastern ...
Breaking Medicine Technology:Medifirst Solutions, Inc. Announces Update To Shareholders 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
... LIUZHOU CITY, China , July 19 ... CNBI), ("China BCT" or the,"Company"), a leading pharmaceutical distributor, ... Province , China , today,announced that on ... Public,Accountants, A Professional Corporation, Glendale, California ("PKF,California"), ...
... 19 "This is a historic day for HIV prevention research. ... gel can help to prevent sexual transmission of HIV infection," said AVAC ... landmark microbicide trial presented today at the International AIDS Conference in ... "We believe ...
Cached Medicine Technology:China BCT Announces Auditor Change Within PKF Network 2China BCT Announces Auditor Change Within PKF Network 3AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 2AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 3AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 4
(Date:5/22/2013)... (PRWEB) May 22, 2013 Nearly 50,000 ... Appeals (BVA) in fiscal year 2012, with even more—54,033—expected ... waiting longer for a decision as the agency reports ... which provides veterans disability appeal services. The ... Veterans Affairs. , Although the BVA received 49,611 cases ...
(Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- People ... likely to attempt suicide, whether or not they also ... a new study. "Clinicians who are seeing patients ... at increased risk of suicide," said study co-author Mark ... Resource and Evaluation Center in Ann Arbor, Mich. ...
(Date:5/22/2013)... 2013 Bodybuilding.com is giving back ... 27, 2013) Bodybuilding.com will be donating $1 from EVERY purchase ... , “We are extremely grateful for the men and women ... Ryan DeLuca, CEO and founder of Bodybuilding.com. “It’s an honor ... so much. Hire Heroes USA is an amazing organization that ...
(Date:5/22/2013)... City, UT (PRWEB) May 22, 2013 ... the Alabama Health Insurance Exchange . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, beginning in 2014 ... insurance coverage for individuals and small businesses will become ...
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Migraines and depression ... new research indicates the combination of the two may ... brain. , , Already aware that people with migraines ... determine if having both conditions together affected total brain ... -- isn,t alarming, study authors said, but needs further ...
Breaking Medicine News(10 mins):Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3
... Boys with asthma who are exposed to environmental tobacco ... other behavioral problems, according to researchers at Cincinnati Children,s ... ahead of print by the Journal of Developmental ... increase along with higher exposure levels, but they added ...
... Transgenomic,(OTC Bulletin Board: TBIO) today announced ... Texas through its technology transfer entity, the,Research ... exclusive license,to patents covering a method for ... the basis for the development of diagnostic ...
... - Over 11,000 people raced to wellness in Louisiana ... challenge event was the latest in a series of programs ... is part of a growing movement to help people live ... one of the country,s most obese states, Louisiana is continuing ...
... (Dec. 4, 2008) In a statewide survey of ... Research Institute at Harbor-UCLA Medical Center (LA BioMed) are ... according to the December issue of Los Angeles magazine. ... more than 30,000 medical professionals to compile the 2008 ...
... released the following statement in reaction to the latest Congressional ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ) , ... that will only get worse if we allow America,s biggest ... these corporations go under -- taking with them the men ...
... division of Patient Safety Technologies, Inc. (OTC Bulletin Board:,PSTX), today ... become,one of its partners in helping to create a safer, ... at Leapfrog,s next two meetings in,December and February. , ... privileged to enter into an affiliation with,Leapfrog. We share a ...
Cached Medicine News:Health News:Study strengthens link between tobacco smoke and behavioral problems in boys with asthma 2Health News:Study strengthens link between tobacco smoke and behavioral problems in boys with asthma 3Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 2Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 3Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 4Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 5Health News:Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology 6Health News:High Tech Wellness Inspires Louisiana 2Health News:LA BioMed researchers among Southern California Super Doctors 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 3Health News:SurgiCount Medical Joins The Leapfrog Group 2
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
... 4.2 Image Processing Video Camera is our ... exclusive ACMI Image Processing (IP) technology, the ... and detail. Exciting new features, enhanced image ... 4.2 an exceptional value. All IP 4.2 ...
Medicine Products: